Shahrzad Bazargan-Hejazi, PhD


Adjunct Professor

Phone: Organizational affiliation:
323-357-3464 UCLA University
E-mail: Department:




Shahrzad Bazargan-Hejazi, PhD. She is a Professor of Medical Sociology in the Department of Psychiatry and Pediatrics at Charles Drew University of Medicine and Science (CDU) in Los Angeles, California with a joint appointment as an Adjunct Professor in the Department of Psychiatry at David Geffen School of Medicine at University of California at Los Angeles (UCLA), Los Angeles, CA. As a Medical sociologist and health services researcher she has been the lead investigator and co-investigator in several projects related to the social aspects of disease and illness; youth empowerment health advocacy projects; family and community violence prevention programs for teens and adolescents; and health services utilization improvement for Head Start families, and underserved minorities, particularly those affected by depression, injury, violence, and alcohol problems.



Certificate Paper

Ph.D.: Medical Sociolog,y State University of New York at Buffalo 1993.
M.A.: Sociology, State University of New York at Buffalo 1987
B.A.: Sociology, State University of New York at Buffalo, 1982


2014-Present Professor (tenure track) of Medicine, Baylor College of Medicine
2008-2014 Associate Professor of Medicine, Baylor College of Medicine
2000-2008 Assistant Professor of Medicine, Baylor College of Medicine
2005-2010 Adjunct Assistant Professor of Medicine, MD Anderson Cancer Center
  1. Sharafkhaneh A, Spiegelman AM, Main K, Tavakoli-Tabasi S, Lan C, Musher D. Mortality in Patients Admitted for Concurrent COPD Exacerbation and Pneumonia. COPD. 2017 Feb; 14(1):23-29. PMID: 27661473.
    View in: PubMed
  2. Kim V, Zhao H, Boriek AM, Anzueto A, Soler X, Bhatt SP, Rennard SI, Wise R, Comellas A, Ramsdell JW, Kinney GL, Han MK, Martinez CH, Yen A, Black-Shinn J, Porszasz J, Criner GJ, Hanania NA, Sharafkhaneh A, Crapo JD, Make BJ, Silverman EK, Curtis JL. Persistent and Newly Developed Chronic Bronchitis Are Associated with Worse Outcomes in Chronic Obstructive Pulmonary Disease. Ann Am Thorac Soc. 2016 Jul; 13(7):1016-25. PMID: 27158740.
    View in: PubMed
  3. Sharafkhaneh A, Hirshkowitz M. Can You Hear Me Now? J Clin Sleep Med. 2016; 12(5):641-2. PMID: 27092694; PMCID: PMC4865547 [Available on 11/15/16].
  4. Mudambi L, Spiegelman A, Geron D, Hirshkowitz M, Mokhlesi B, Shaib Y, Velamuri S, Lan CO, Sharafkhaneh A. Obstructive Sleep Apnea Is Not Associated with Higher Health Care Use after Colonoscopy under Conscious Sedation. Ann Am Thorac Soc. 2016 Mar; 13(3):419-24. PMID: 26871998.
    View in: PubMed
  5. Kheirkhah P, Feng Q, Travis LM, Tavakoli-Tabasi S, Sharafkhaneh A. Prevalence, predictors and economic consequences of no-shows. BMC Health Serv Res. 2016; 16(1):13. PMID: 26769153.
    View in: PubMed
  6. Sharafkhaneh A, Katigbak J, Hirshkowitz M, Sharafkhaneh H, Sharafkhaneh SP, Ballantyne CM, Bozkurt B, Nambi V. Severity of hypoxia modulates effect of CPAP on myocardial stress as measured by highly sensitive troponin T. Respir Res. 2015; 16:126. PMID: 26475736.
    View in: PubMed
  7. Singh S, Kanbar-Agha F, Sharafkhaneh A. Novel Aerosol Delivery Devices. Semin Respir Crit Care Med. 2015 Aug; 36(4):543-51. PMID: 26238640.
    View in: PubMed
  8. Bujarski S, Parulekar AD, Sharafkhaneh A, Hanania NA. The asthma COPD overlap syndrome (ACOS). Curr Allergy Asthma Rep. 2015 Mar; 15(3):509. PMID: 25712010.
    View in: PubMed
  9. Attia EF, Akgün KM, Wongtrakool C, Goetz MB, Rodriguez-Barradas MC, Rimland D, Brown ST, Soo Hoo GW, Kim J, Lee PJ, Schnapp LM, Sharafkhaneh A, Justice AC, Crothers K. Increased risk of radiographic emphysema in HIV is associated with elevated soluble CD14 and nadir CD4. Chest. 2014 Dec; 146(6):1543-53. PMID: 25080158; PMCID: PMC4251616.
  10. Hirshkowitz M, Sharafkhaneh A. A telemedicine program for diagnosis and management of sleep-disordered breathing: the fast-track for sleep apnea tele-sleep program. Semin Respir Crit Care Med. 2014 Oct; 35(5):560-70. PMID: 25353101.
    View in: PubMed
  11. Bowler RP, Kim V, Regan E, Williams AA, Santorico SA, Make BJ, Lynch DA, Hokanson JE, Washko GR, Bercz P, Soler X, Marchetti N, Criner GJ, Ramsdell J, Han MK, Demeo D, Anzueto A, Comellas A, Crapo JD, Dransfield M, Wells JM, Hersh CP, MacIntyre N, Martinez F, Nath HP, Niewoehner D, Sciurba F, Sharafkhaneh A, Silverman EK, van Beek EJ, Wilson C, Wendt C, Wise RA. Prediction of acute respiratory disease in current and former smokers with and without COPD. Chest. 2014 Oct; 146(4):941-50. PMID: 24945159; PMCID: PMC4188150.
  12. Qureshi H, Sharafkhaneh A, Hanania NA. Chronic obstructive pulmonary disease exacerbations: latest evidence and clinical implications. Ther Adv Chronic Dis. 2014 Sep; 5(5):212-27. PMID: 25177479; PMCID: PMC4131503.
  13. Sharafkhaneh A, Altan AE, Colice GL, Hanania NA, Donohue JF, Kurlander JL, Rodriguez-Roisin R, Altman PR. A simple rule to identify patients with chronic obstructive pulmonary disease who may need treatment reevaluation. Respir Med. 2014 Sep; 108(9):1310-20. PMID: 25130680.
    View in: PubMed
  14. Crothers K, McGinnis K, Kleerup E, Wongtrakool C, Hoo GS, Kim J, Sharafkhaneh A, Huang L, Luo Z, Thompson B, Diaz P, Kirk GD, Rom W, Detels R, Kingsley L, Morris A. HIV infection is associated with reduced pulmonary diffusing capacity. J Acquir Immune Defic Syndr. 2013 Nov 1; 64(3):271-8. PMID: 23979001; PMCID: PMC3845879.
  15. Sharafkhaneh A, Wolf RA, Goodnight S, Hanania NA, Make BJ, Tashkin DP. Perceptions and attitudes toward the use of nebulized therapy for COPD: patient and caregiver perspectives. COPD. 2013 Aug; 10(4):482-92. PMID: 23875742.
    View in: PubMed
  16. Sharafkhaneh A, Majid H, Gross NJ. Safety and tolerability of inhalational anticholinergics in COPD. Drug Healthc Patient Saf. 2013; 5:49-55. PMID: 23526112; PMCID: PMC3596125.
  17. Fujimoto J, Kadara H, Garcia MM, Kabbout M, Behrens C, Liu DD, Lee JJ, Solis LM, Kim ES, Kalhor N, Moran C, Sharafkhaneh A, Lotan R, Wistuba II. G-protein coupled receptor family C, group 5, member A (GPRC5A) expression is decreased in the adjacent field and normal bronchial epithelia of patients with chronic obstructive pulmonary disease and non-small-cell lung cancer. J Thorac Oncol. 2012 Dec; 7(12):1747-54. PMID: 23154545; PMCID: PMC3622592.
  18. Al-shair K, Muellerova H, Yorke J, Rennard SI, Wouters EF, Hanania NA, Sharafkhaneh A, Vestbo J. Examining fatigue in COPD: development, validity and reliability of a modified version of FACIT-F scale. Health Qual Life Outcomes. 2012; 10:100. PMID: 22913289; PMCID: PMC3491053.
  19. Fan VS, Gaziano JM, Lew R, Bourbeau J, Adams SG, Leatherman S, Thwin SS, Huang GD, Robbins R, Sriram PS, Sharafkhaneh A, Mador MJ, Sarosi G, Panos RJ, Rastogi P, Wagner TH, Mazzuca SA, Shannon C, Colling C, Liang MH, Stoller JK, Fiore L, Niewoehner DE. A comprehensive care management program to prevent chronic obstructive pulmonary disease hospitalizations: a randomized, controlled trial. Ann Intern Med. 2012 May 15; 156(10):673-83. PMID: 22586006.
    View in: PubMed
  20. A combined pulmonary-radiology workshop for visual evaluation of COPD: study design, chest CT findings and concordance with quantitative evaluation. COPD. 2012 Apr; 9(2):151-9. PMID: 22429093; PMCID: PMC3752926.
  21. Sharafkhaneh A, Southard JG, Goldman M, Uryniak T, Martin UJ. Effect of budesonide/formoterol pMDI on COPD exacerbations: a double-blind, randomized study. Respir Med. 2012 Feb; 106(2):257-68. PMID: 22033040.
    View in: PubMed
  22. Garcia JM, Sharafkhaneh H, Hirshkowitz M, Elkhatib R, Sharafkhaneh A. Weight and metabolic effects of CPAP in obstructive sleep apnea patients with obesity. Respir Res. 2011; 12(1):80. PMID: 21676224; PMCID: PMC3146428.
  23. McCurdy MR, Sharafkhaneh A, Abdel-Monem H, Rojo J, Tittel FK. Exhaled nitric oxide parameters and functional capacity in chronic obstructive pulmonary disease. J Breath Res. 2011 Mar; 5(1):016003. PMID: 21378438.
    View in: PubMed
  24. Hanania NA, Sharafkhaneh A, Celli B, Decramer M, Lystig T, Kesten S, Tashkin D. Acute bronchodilator responsiveness and health outcomes in COPD patients in the UPLIFT trial. Respir Res. 2011; 12:6. PMID: 21219660; PMCID: PMC3027109.
  25. Hirshkowitz M, Sharafkhaneh A. Sleep and genitourinary systems: physiology and disorders. Handb Clin Neurol. 2011; 98:355-62. PMID: 21056197.
    View in: PubMed
  26. Hirshkowitz M, Sharafkhaneh A. Normal sleep-recording and scoring techniques. Handb Clin Neurol. 2011; 98:29-43. PMID: 21056177.
    View in: PubMed
  27. Hanania NA, Sharma G, Sharafkhaneh A. COPD in the elderly patient. Semin Respir Crit Care Med. 2010 Oct; 31(5):596-606. PMID: 20941660.
    View in: PubMed
  28. Sharafkhaneh A, Mattewal AS, Abraham VM, Dronavalli G, Hanania NA. Budesonide/formoterol combination in COPD: a US perspective. Int J Chron Obstruct Pulmon Dis. 2010; 5:357-66. PMID: 21037960; PMCID: PMC2962302.
  29. Hanania NA, Müllerova H, Locantore NW, Vestbo J, Watkins ML, Wouters EF, Rennard SI, Sharafkhaneh A. Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort. Am J Respir Crit Care Med. 2011 Mar 1; 183(5):604-11. PMID: 20889909.
    View in: PubMed
  30. Sharafkhaneh A, Petersen NJ, Yu HJ, Dalal AA, Johnson ML, Hanania NA. Burden of COPD in a government health care system: a retrospective observational study using data from the US Veterans Affairs population. Int J Chron Obstruct Pulmon Dis. 2010; 5:125-32. PMID: 20461144; PMCID: PMC2866562.
  31. Kumar S, Sharafkhaneh A, Edmonds J, Schultz R, Hopkins B. Treatment of vns-induced laryngospasm with botulinum toxin. Neurology. 2009 Nov 24; 73(21):1808-10. PMID: 19933985.
    View in: PubMed
  32. Sharafkhaneh A, Jayaraman G, Kaleekal T, Sharafkhaneh H, Hirshkowitz M. Sleep disorders and their management in patients with COPD. Ther Adv Respir Dis. 2009 Dec; 3(6):309-18. PMID: 19880428.
    View in: PubMed
  33. Niewoehner DE, Lapidus R, Cote C, Sharafkhaneh A, Plautz M, Johnson P, Kesten S. Therapeutic conversion of the combination of ipratropium and albuterol to tiotropium in patients with chronic obstructive pulmonary disease. Pulm Pharmacol Ther. 2009 Dec; 22(6):587-92. PMID: 19737620.
    View in: PubMed
  34. Bailey WC, Sciurba FC, Hanania NA, Donohue JF, Ferguson GT, Zibrak JD, Sharafkhaneh A, Marcus P, Rosa K, Piault EC, Martinez FJ. Development and validation of the Chronic Obstructive Pulmonary Disease Assessment Questionnaire (COPD-AQ). Prim Care Respir J. 2009 Sep; 18(3):198-207. PMID: 19492178.
    View in: PubMed
  35. Jayaraman G, Sharafkhaneh H, Hirshkowitz M, Sharafkhaneh A. Pharmacotherapy of obstructive sleep apnea. Ther Adv Respir Dis. 2008 Dec; 2(6):375-86. PMID: 19124383.
    View in: PubMed
  36. Cote C, Pearle JL, Sharafkhaneh A, Spangenthal S. Faster onset of action of formoterol versus salmeterol in patients with chronic obstructive pulmonary disease: a multicenter, randomized study. Pulm Pharmacol Ther. 2009 Feb; 22(1):44-9. PMID: 19071226.
    View in: PubMed
  37. Washko GR, Criner GJ, Mohsenifar Z, Sciurba FC, Sharafkhaneh A, Make BJ, Hoffman EA, Reilly JJ. Computed tomographic-based quantification of emphysema and correlation to pulmonary function and mechanics. COPD. 2008 Jun; 5(3):177-86. PMID: 18568842.
    View in: PubMed
  38. Kim V, Benditt JO, Wise RA, Sharafkhaneh A. Oxygen therapy in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2008 May 1; 5(4):513-8. PMID: 18453364; PMCID: PMC2645328.
  39. Sharafkhaneh A, Hanania NA, Kim V. Pathogenesis of emphysema: from the bench to the bedside. Proc Am Thorac Soc. 2008 May 1; 5(4):475-7. PMID: 18453358; PMCID: PMC2645322.
  40. Sharafkhaneh A, Falk JA, Minai OA, Lipson DA. Overview of the perioperative management of lung volume reduction surgery patients. Proc Am Thorac Soc. 2008 May 1; 5(4):438-41. PMID: 18453352; PMCID: PMC2645316.
  41. Fessler HE, Scharf SM, Ingenito EP, McKenna RJ, Sharafkhaneh A. Physiologic basis for improved pulmonary function after lung volume reduction. Proc Am Thorac Soc. 2008 May 1; 5(4):416-20. PMID: 18453348; PMCID: PMC2645312.
  42. Criner GJ, Sharafkhaneh A, Player R, Conoscenti CS, Johnson P, Keyser MT, Cassino C. Efficacy of tiotropium inhalation powder in african-american patients with chronic obstructive pulmonary disease. COPD. 2008 Feb; 5(1):35-41. PMID: 18259973.
    View in: PubMed
  43. Sharafkhaneh A, Velamuri S, Badmaev V, Lan C, Hanania N. The potential role of natural agents in treatment of airway inflammation. Ther Adv Respir Dis. 2007 Dec; 1(2):105-20. PMID: 19124352.
    View in: PubMed
  44. Kunik ME, Veazey C, Cully JA, Souchek J, Graham DP, Hopko D, Carter R, Sharafkhaneh A, Goepfert EJ, Wray N, Stanley MA. COPD education and cognitive behavioral therapy group treatment for clinically significant symptoms of depression and anxiety in COPD patients: a randomized controlled trial. Psychol Med. 2008 Mar; 38(3):385-96. PMID: 17922939.
    View in: PubMed
  45. Hanania NA, Sharafkhaneh A. Update on the pharmacologic therapy for chronic obstructive pulmonary disease. Clin Chest Med. 2007 Sep; 28(3):589-607, vi-vii. PMID: 17720046.
    View in: PubMed
  46. Xu Y, Jagannath C, Liu XD, Sharafkhaneh A, Kolodziejska KE, Eissa NT. Toll-like receptor 4 is a sensor for autophagy associated with innate immunity. Immunity. 2007 Jul; 27(1):135-44. PMID: 17658277; PMCID: PMC2680670.
  47. Hogg JC, Chu FS, Tan WC, Sin DD, Patel SA, Pare PD, Martinez FJ, Rogers RM, Make BJ, Criner GJ, Cherniack RM, Sharafkhaneh A, Luketich JD, Coxson HO, Elliott WM, Sciurba FC. Survival after lung volume reduction in chronic obstructive pulmonary disease: insights from small airway pathology. Am J Respir Crit Care Med. 2007 Sep 1; 176(5):454-9. PMID: 17556723; PMCID: PMC1976540.
  48. Niewoehner DE, Lokhnygina Y, Rice K, Kuschner WG, Sharafkhaneh A, Sarosi GA, Krumpe P, Pieper K, Kesten S. Risk indexes for exacerbations and hospitalizations due to COPD. Chest. 2007 Jan; 131(1):20-8. PMID: 17218552.
    View in: PubMed
  49. Sharafkhaneh A, Sharafkhaneh H, Bredikus A, Guilleminault C, Bozkurt B, Hirshkowitz M. Effect of atrial overdrive pacing on obstructive sleep apnea in patients with systolic heart failure. Sleep Med. 2007 Jan; 8(1):31-6. PMID: 17157066.
    View in: PubMed
  50. Sharafkhaneh A, Babb TG, Officer TM, Hanania NA, Sharafkhaneh H, Boriek AM. The confounding effects of thoracic gas compression on measurement of acute bronchodilator response. Am J Respir Crit Care Med. 2007 Feb 15; 175(4):330-5. PMID: 17110648; PMCID: PMC1899266.
  51. Hanania NA, Moore RH, Zimmerman JL, Miller CT, Bag R, Sharafkhaneh A, Dickey BF. The role of intrinsic efficacy in determining response to a beta2-agonist in acute severe asthma. Respir Med. 2007 May; 101(5):1007-14. PMID: 17052901.
    View in: PubMed
  52. Sciurba FC, Martinez FJ, Rogers RM, Make BJ, Criner GJ, Cherniack RM, Patel SA, Chu F, Coxson HO, Sharafkhaneh A, Elliot M, Luketich JD, Hogg JC. Relationship between pathologic characteristics of peripheral airways and outcome after lung volume reduction surgery in severe chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2006 Aug; 3(6):533-4. PMID: 16921138; PMCID: PMC2647645.
  53. Cully JA, Graham DP, Stanley MA, Ferguson CJ, Sharafkhaneh A, Souchek J, Kunik ME. Quality of life in patients with chronic obstructive pulmonary disease and comorbid anxiety or depression. Psychosomatics. 2006 Jul-Aug; 47(4):312-9. PMID: 16844889.
    View in: PubMed
  54. Williams OW, Sharafkhaneh A, Kim V, Dickey BF, Evans CM. Airway mucus: From production to secretion. Am J Respir Cell Mol Biol. 2006 May; 34(5):527-36. PMID: 16415249; PMCID: PMC2644218.
  55. Hirshkowitz M, Sharafkhaneh A. Clinical and technologic approaches to sleep evaluation. Neurol Clin. 2005 Nov; 23(4):991-1005, v-vi. PMID: 16243612.
    View in: PubMed
  56. Sharafkhaneh A, Giray N, Richardson P, Young T, Hirshkowitz M. Association of psychiatric disorders and sleep apnea in a large cohort. Sleep. 2005 Nov; 28(11):1405-11. PMID: 16335330.
    View in: PubMed
  57. Sharafkhaneh A, Goodnight-White S, Officer TM, Rodarte JR, Boriek AM. Altered thoracic gas compression contributes to improvement in spirometry with lung volume reduction surgery. Thorax. 2005 Apr; 60(4):288-92. PMID: 15790983; PMCID: PMC1747381.
  58. Hirshkowitz M, Sharafkhaneh A. Positive airway pressure therapy of OSA. Semin Respir Crit Care Med. 2005 Feb; 26(1):68-79. PMID: 16052419.
    View in: PubMed
  59. Hirshkowitz M, Sharafkhaneh A. On measurement consistency and other hobgoblins. Sleep. 2004 Aug 1; 27(5):847-8. PMID: 15453541.
    View in: PubMed
  60. Sharafkhaneh A, Richardson P, Hirshkowitz M. Sleep apnea in a high risk population: a study of Veterans Health Administration beneficiaries. Sleep Med. 2004 Jul; 5(4):345-50. PMID: 15222990.
    View in: PubMed
  61. Sharafkhaneh A, Officer TM, Goodnight-White S, Rodarte JR, Boriek AM. Novel method for measuring effects of gas compression on expiratory flow. Am J Physiol Regul Integr Comp Physiol. 2004 Aug; 287(2):R479-84. PMID: 15117729.
    View in: PubMed
  62. Sharafkhaneh A, Baaklini W, Gorin AB, Green L. Yield of transbronchial needle aspiration in diagnosis of mediastinal lesions. Chest. 2003 Dec; 124(6):2131-5. PMID: 14665491.
    View in: PubMed
  63. Sharafkhaneh A, Hirshkowitz M. Contextual factors and perceived self-reported sleepiness: a preliminary report. Sleep Med. 2003 Jul; 4(4):327-31. PMID: 14592305.
    View in: PubMed
  64. Hanania NA, Sharafkhaneh A, Barber R, Dickey BF. Beta-agonist intrinsic efficacy: measurement and clinical significance. Am J Respir Crit Care Med. 2002 May 15; 165(10):1353-8. PMID: 12016095.
    View in: PubMed
  65. Hirshkowitz M, Sharafkhaneh A. Sleep tools. Chest. 2001 May; 119(5):1303. PMID: 11348932.
    View in: PubMed
  66. Friedman HS, Wattanasuwan N, Sharafkhaneh A, Win M, Mallipeddi D, Khan IA, Dai CP. The comparative effects of drive and test stimulus intensity on myocardial excitability and vulnerability. Pacing Clin Electrophysiol. 2000 Jan; 23(1):84-95. PMID: 10666757.
    View in: PubMed
  67. Friedman HS, Rodney E, Sinha B, Sharafkhaneh A, Wattanasuwan N, Win M, Mallipeddi D, Sinha A, Hussain A, Dai CP. Verapamil prolongs atrial fibrillation by evoking an intense sympathetic neurohumoral effect. J Investig Med. 1999 Jul; 47(6):293-303. PMID: 10431484.
    View in: PubMed
  68. Friedman HS, Sinha B, Tun A, Pasha R, Sharafkhaneh A, Bharadwaj A. Zones of atrial vulnerability. Relationships to basic cycle length. Circulation. 1996 Sep 15; 94(6):1456-64. PMID: 8823006.
    View in: PubMed

Other Details


Honors & Awards

2014 Fulbright and Jaworski Award for Educational Leadership, Baylor College
of Medicine
2014 Office of Rural Health, VHA. Three years funding ($194,000 annual support)
to develop telemedicine program to manage insomnia.
2012 Office of Rural Health, VHA. Three years funding ($200,000 annual support)
to develop telemedicine program to diagnose and manage sleep
disordered breathing.
2005 Fulbright and Jaworski Award for Faculty Excellence in Teaching and
Evaluation, Baylor College of Medicine
2002 Joe Rodarte Young Investigator Award, Baylor College of Medicine
1994 Intern-of-The-Year in Internal Medicine, Long Island College Hospital
1988 Top 10% Iranian Internship Entrance Exam
Tehran University of Medical Sciences
1982 Top 1% Iranian National University Entry Exam
Tehran, Iran
 Board Eligibility/Certification
2010 Recertification in Critical Care Medicine, ABIM
2009 Recertification in Pulmonary Diseases, ABIM
2007 Recertification in Internal Medicine, ABIM
2007 Sleep Medicine, ABIM
2001 American Board of Sleep Medicine (ABSM)
2000 Critical Care Medicine, ABIM
1999 Pulmonary Diseases, ABIM
1997 Internal Medicine, ABIM
 Other Certification
2002 Baylor College of Medicine, Certificate of Added Qualification in Clinical
1994 Certificate of the Educational Commission for Foreign Medical
Graduates (ECFMG)
 Medical Licensure
1999 Texas- Active, K7100
Other non-academic positions: (with locations, titles, dates of employment)
2007-Present Program Director, Sleep Medicine Fellowship Program, Baylor College of
2007-Present Sleep Medicine Fellowship Site Director, Sleep Disorders & Research
Center, Michael DeBakey VA Medical Center